Medacta Group SA (SWX:MOVE)
108.60
-1.40 (-1.27%)
Nov 12, 2026, 5:30 PM CET
Medacta Group Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Medacta Group stock has a consensus rating of "Buy" and an average price target of CHF 151.84. The average 1-year stock price forecast is 39.82% higher than the current stock price, while the lowest is CHF 112.36 (+3.46%) and the highest is CHF 174.92 (+61.07%).
Price Target: CHF 151.84 (+39.82%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Medacta Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold Maintains CHF 121.00 → CHF 112.00 | Hold | Maintains | CHF 121.00 → CHF 112.00 | +3.13% | Nov 9, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Maintains CHF 185.00 → CHF 180.00 | Buy | Maintains | CHF 185.00 → CHF 180.00 | +65.75% | Sep 11, 2026 |
| UBS | UBS | Hold Maintains CHF 151.00 → CHF 148.00 | Hold | Maintains | CHF 151.00 → CHF 148.00 | +36.28% | Jul 21, 2026 |
Financial Forecast
Revenue This Year
759.28M
from 683.83M
Increased by 11.03%
Revenue Next Year
855.20M
from 759.28M
Increased by 12.63%
EPS This Year
4.75
from 4.33
Increased by 9.57%
EPS Next Year
5.63
from 4.75
Increased by 18.52%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.